The Nail in the Coffin for COVID

This medical breakthrough will blow your mind... This medical breakthrough will blow your mind... Energy and Capital: Practical Investment Analysis in the new Energy Economy [Energy and Capital logo] The Nail in the Coffin for COVID By Keith Kohl | November 11, 2021 - Baltimore, MD My latest discovery is going to blow your mind... Better yet, I believe it’s going to put an end to the world’s deadly pandemic. A new nasal spray works to fight off COVID and stop it from spreading, no matter the strain. That’s right — scientists are predicting that this nasal spray could be effective against multiple COVID variants and any new ones that pop up in the future. It’s all thanks to a powerful, all-natural immunity booster called “Alpha 2B”... Which can make symptoms disappear within just seven days! Better still, this company’s scientists have a history of producing breakthrough treatments and drugs. But this nasal spray could top them all. Because this tiny firm is the ONLY company on the planet harnessing the secret ingredient in this nasal spray as a treatment for viruses... Which is why it’s critical for you to act fast. [Right now, this tiny stock trades for less than $1.]( But soon, it could trade for multiples of that. Mark my words, this is going to be BIG. FDA trials are already underway... And this COVID-killing nasal spray could receive fast-track FDA approval, just like the vaccines did.That’s why you need to get in right NOW if you want to bank the biggest gains. [Check out the details before it’s too late.]( To your wealth, [Keith Kohl sig] Keith KohlInvestment Director, Topline Trader P.S. This COVID-killing nasal spray could finally put an end the pandemic once and for all. It’s expected to be even BETTER than the vaccine, taking only seven days to kill the COVID virus and stop symptoms. That’s why I’m recommending this small biotech company for immediate purchase. And I encourage you to [make your move]( before the biggest gains are gone. --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2021, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](